We analyzed SELE expression in our patient cohort (Fig. 5A) and observed significant downregulation of this gene in metastatic disease (localized mean = 3.381, metastatic mean = 0.881, p = 6 × 10–10, Fig. 5B). The gene discussed is SELE; the disease is metastatic neoplasm.